sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Mural Oncology
The Vanguard Group, Inc. has released Form 8.3 in compliance with the Irish Takeover Panel Act. This disclosure pertains to their position in Mural Oncology plc. As of October 20, 2025, Vanguard holds 288,763 ordinary shares at 1.67% of relevant securities. This indicates a significant interest in Mural Oncology.
In recent dealings, Vanguard sold 48 of these shares at a price of 2.09 USD per unit. The form shows no activities in cash-settled or stock-settled derivatives. Vanguard confirms no existing indemnity, agreement or arrangement concerning the securities beyond this disclosure.
This announcement aligns with the rules governing stakes of 1% or more in relevant securities of companies under consideration for a potential takeover or other significant corporate event by the Irish Takeover Panel.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.